NCT06611891View on ClinicalTrials.gov

Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer

PHASE3RecruitingINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions

Breast Cancer Metastatic

Interventions

DRUG

68Ga-DOTATOC

Slow direct intravenous injection

Trial Locations (1)

38043

RECRUITING

CHU Grenoble Alpes, Grenoble

All Listed Sponsors

lead

University Hospital, Grenoble

OTHER